183 related articles for article (PubMed ID: 21575160)
1. Chronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome.
Bixler GV; Vanguilder HD; Brucklacher RM; Kimball SR; Bronson SK; Freeman WM
BMC Med Genomics; 2011 May; 4():40. PubMed ID: 21575160
[TBL] [Abstract][Full Text] [Related]
2. Insulin treatment normalizes retinal neuroinflammation but not markers of synapse loss in diabetic rats.
Masser DR; VanGuilder Starkey HD; Bixler GV; Dunton W; Bronson SK; Freeman WM
Exp Eye Res; 2014 Aug; 125():95-106. PubMed ID: 24931083
[TBL] [Abstract][Full Text] [Related]
3. Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy.
VanGuilder HD; Bixler GV; Kutzler L; Brucklacher RM; Bronson SK; Kimball SR; Freeman WM
PLoS One; 2011 Jan; 6(1):e16271. PubMed ID: 21249158
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of connective tissue growth factor by small interfering ribonucleic acid prevents increase in extracellular matrix molecules in a rodent model of diabetic retinopathy.
Winkler JL; Kedees MH; Guz Y; Teitelman G
Mol Vis; 2012; 18():874-86. PubMed ID: 22511849
[TBL] [Abstract][Full Text] [Related]
5. Protection of exendin-4 analogue in early experimental diabetic retinopathy.
Zhang Y; Wang Q; Zhang J; Lei X; Xu GT; Ye W
Graefes Arch Clin Exp Ophthalmol; 2009 May; 247(5):699-706. PubMed ID: 19084986
[TBL] [Abstract][Full Text] [Related]
6. The retinal proteome in experimental diabetic retinopathy: up-regulation of crystallins and reversal by systemic and periocular insulin.
Fort PE; Freeman WM; Losiewicz MK; Singh RS; Gardner TW
Mol Cell Proteomics; 2009 Apr; 8(4):767-79. PubMed ID: 19049959
[TBL] [Abstract][Full Text] [Related]
7. Expression of acute-phase response proteins in retinal Müller cells in diabetes.
Gerhardinger C; Costa MB; Coulombe MC; Toth I; Hoehn T; Grosu P
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):349-57. PubMed ID: 15623795
[TBL] [Abstract][Full Text] [Related]
8. Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes.
Mima A; Qi W; Hiraoka-Yamomoto J; Park K; Matsumoto M; Kitada M; Li Q; Mizutani K; Yu E; Shimada T; Lee J; Shoelson SE; Jobin C; Rask-Madsen C; King GL
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8424-32. PubMed ID: 23197686
[TBL] [Abstract][Full Text] [Related]
9. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
Zhang H; Gao Y; Zhang J; Wang K; Jin T; Wang H; Ruan K; Wu F; Xu Z
J Ethnopharmacol; 2020 Jun; 255():112773. PubMed ID: 32199990
[TBL] [Abstract][Full Text] [Related]
10. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats.
Zhang Y; Zhang J; Wang Q; Lei X; Chu Q; Xu GT; Ye W
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):278-85. PubMed ID: 20688733
[TBL] [Abstract][Full Text] [Related]
12. Effect of sustained insulin-releasing device made of poly(ethylene glycol) dimethacrylates on retinal function in streptozotocin-induced diabetic rats.
Hoshi A; Nagai N; Daigaku R; Motoyama R; Saijo S; Kaji H; Abe T
J Mater Sci Mater Med; 2020 May; 31(6):52. PubMed ID: 32462459
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
[TBL] [Abstract][Full Text] [Related]
14. Functional changes in the neural retina occur in the absence of mitochondrial dysfunction in a rodent model of diabetic retinopathy.
Masser DR; Otalora L; Clark NW; Kinter MT; Elliott MH; Freeman WM
J Neurochem; 2017 Dec; 143(5):595-608. PubMed ID: 28902411
[TBL] [Abstract][Full Text] [Related]
15. In vivo retinal gene expression in early diabetes.
Joussen AM; Huang S; Poulaki V; Camphausen K; Beecken WD; Kirchhof B; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3047-57. PubMed ID: 11687554
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol exhibits an effect on attenuating retina inflammatory condition and damage of diabetic retinopathy via PON1.
Chen Y; Meng J; Li H; Wei H; Bi F; Liu S; Tang K; Guo H; Liu W
Exp Eye Res; 2019 Apr; 181():356-366. PubMed ID: 30503749
[TBL] [Abstract][Full Text] [Related]
17. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
18. Age-related alterations in retinal neurovascular and inflammatory transcripts.
Van Kirk CA; VanGuilder HD; Young M; Farley JA; Sonntag WE; Freeman WM
Mol Vis; 2011; 17():1261-74. PubMed ID: 21633715
[TBL] [Abstract][Full Text] [Related]
19. RNA sequencing reveals retinal transcriptome changes in STZ-induced diabetic rats.
Liu YJ; Lian ZY; Liu G; Zhou HY; Yang HJ
Mol Med Rep; 2016 Mar; 13(3):2101-9. PubMed ID: 26781437
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of genes for oxidative phosphorylation and protein turnover in diabetic mouse retina.
Adachi-Uehara N; Kato M; Nimura Y; Seki N; Ishihara A; Matsumoto E; Iwase K; Ohtsuka S; Kodama H; Mizota A; Yamamoto S; Adachi-Usami E; Takiguchi M
Exp Eye Res; 2006 Oct; 83(4):849-57. PubMed ID: 16780836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
